So there's added benefit of using this type of medication in someone who has obesity and has harm to their health
In the Phase 2 trial, the most commonly reported adverse events were gastrointestinal in nature including nausea, vomiting, diarrhoea, and constipation consistent with the side effect profile seen with other GLP-1-based therapies
Reconstituted solution exposed to room temperature for more than a few hours, or to direct heat or freeze-thaw cycles, should be discarded
Progress on a GLP-1 also depends on dose timing, food tolerance, protein, fiber, water, side effects, and consistency
For help managing injection-related [side effects](/guides/retatrutide-side-effects-management-guide), see our companion guide
Common locations for GLP-1 medication-related cramps: Calf muscles : Frequently reported, especially nocturnal cramps Feet and toes : Often presenting as painful curling or spasms Thigh muscles : Less commonly affected but reported by some patients Abdominal muscles : May be confused with digestive side effects Hands : Occasionally reported, especially with electrolyte imbalances Cramp characteristics: Duration : Typically last from a few seconds to several minutes Intensity : Range from mild tightness to painful spasms Timing : More common at night or after physical activity Trigger patterns : May increase after dose increases or with dehydration Online patient discussions reveal significant individual variation in cramping experiences
.png)
